- Home
- CFSB vs INAB Comparison
CFSB vs INAB Comparison
Compare CFSB & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- INAB
- Stock Information
- Founded
- CFSB 1889
- INAB 2016
- Country
- CFSB United States
- INAB United States
- Employees
- CFSB N/A
- INAB N/A
- Industry
- CFSB Major Banks
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- CFSB Finance
- INAB Health Care
- Exchange
- CFSB Nasdaq
- INAB Nasdaq
- Market Cap
- CFSB 44.7M
- INAB 24.0M
- IPO Year
- CFSB N/A
- INAB 2021
- Fundamental
- Price
- CFSB $6.75
- INAB $0.25
- Analyst Decision
- CFSB
- INAB Strong Buy
- Analyst Count
- CFSB 0
- INAB 3
- Target Price
- CFSB N/A
- INAB $7.75
- AVG Volume (30 Days)
- CFSB 8.9K
- INAB 748.9K
- Earning Date
- CFSB 01-24-2025
- INAB 11-12-2024
- Dividend Yield
- CFSB N/A
- INAB N/A
- EPS Growth
- CFSB N/A
- INAB N/A
- EPS
- CFSB N/A
- INAB N/A
- Revenue
- CFSB $7,444,000.00
- INAB N/A
- Revenue This Year
- CFSB N/A
- INAB N/A
- Revenue Next Year
- CFSB N/A
- INAB N/A
- P/E Ratio
- CFSB N/A
- INAB N/A
- Revenue Growth
- CFSB N/A
- INAB N/A
- 52 Week Low
- CFSB $6.21
- INAB $0.22
- 52 Week High
- CFSB $7.95
- INAB $1.93
- Technical
- Relative Strength Index (RSI)
- CFSB 52.19
- INAB 39.26
- Support Level
- CFSB $6.60
- INAB $0.28
- Resistance Level
- CFSB $6.82
- INAB $0.32
- Average True Range (ATR)
- CFSB 0.12
- INAB 0.03
- MACD
- CFSB 0.01
- INAB -0.01
- Stochastic Oscillator
- CFSB 79.07
- INAB 13.73
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.